Reporting of adverse drug reactions

Whether you are a healthcare professional, patient, or in any other role, reporting a suspected adverse drug reaction actively contributes to the continuous monitoring of the safety and quality of our medicinal products.

If you would like to report a suspected adverse reaction related to our drugs, please refer to the contact details provided below. Bear in mind that all information gathered during the reporting of an adverse reaction is kept confidential and anonymized, ensuring the anonymity of both the reporter and the patient.

Greece

T: +30 210 8771 500

Hematology, Oncology, Immunology and Inflammatory diseases, Rare diseases

F: +30 210 6826 277

E: pharmacovigilance@genesispharma.com

Central Nervous System and Rheumatology diseases

F: +30 210 6834 361

E: pharmacovigilance-CS@genesispharma.com

POST: GENESIS Pharma S.A., (att: Pharmacovigilance Department), 270 Kifissias Avenue, Halandri, 152 32 Athens

Cyprus

T: +357 22 765 715

Hematology, Oncology, Immunology, Inflammatory diseases, Rare diseases

E: phv-cyprus@genesispharmagroup.com

Central Nervous System and Rheumatology diseases

E: phv-CNS-cyprus@genesispharmagroup.com

Kosovo